DA
PASG icon

Denali Advisors’s Passage Bio PASG Stock Holding History

Denali Advisors’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-540
Closed -$25K – 398
2022
Q2 		$25K Hold
540
– – 0.01% 284
2022
Q1 		$33K Buy
540
+100
+23% +$8.24K 0.01% 288
2021
Q4 		$56K Buy
+440
New +$71.9K 0.02% 238

Other funds holding PASG

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Denali Advisors's PASG Position: Q3 2022 in Review

Denali Advisors sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 540 shares — an estimated $25K sold.

Denali Advisors first reported a position in PASG in Q4 2021 and held it in 3 quarters. The position peaked at $56K in Q4 2021. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • Denali Advisors reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • Denali Advisors sold 540 Passage Bio shares in Q3 2022, an estimated $25K.
  • Denali Advisors first reported a position in Passage Bio in Q4 2021 and held it in 3 quarters.
  • Denali Advisors's Passage Bio position peaked at $56K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on Denali Advisors's 13F filing for Q3 2022, filed 25 Oct 2022.